Ginkgo Bioworks Holdings Financial Flexibility Index
Ginkgo Bioworks Holdings financial flexibility index. Ginkgo Bioworks Holdings (DNA) has a Financial Flexibility Index of -0.07x as of June 2026. Free cash flow of $-41.65 Million (operating CF $-44.27 Million minus capex $2.62 Million) represents 0% of total liabilities ($569.76 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Ginkgo Bioworks Holdings (2019–2025)
Financial flexibility index of Ginkgo Bioworks Holdings from 2019 to 2025. Historical Financial Flexibility Index trend for Ginkgo Bioworks Holdings across 7 annual periods. Explore DNA debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Ginkgo Bioworks Holdings Financial Flexibility Index by Year (2019–2025)
Ginkgo Bioworks Holdings financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Ginkgo Bioworks Holdings. For the full cash flow conversion analysis, see Ginkgo Bioworks Holdings (DNA) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | $-163.39 Million | $-171.06 Million | $611.11 Million | ▲ +31.2% |
| 2024 | -0.39x | $-257.04 Million | $-319.58 Million | $661.39 Million | ▲ +13.3% |
| 2023 | -0.45x | $-254.70 Million | $-295.50 Million | $568.19 Million | ▼ -80.1% |
| 2022 | -0.25x | $-199.93 Million | $-252.20 Million | $803.04 Million | ▲ +36.5% |
| 2021 | -0.39x | $-197.30 Million | $-253.82 Million | $503.61 Million | ▼ -3.0% |
| 2020 | -0.38x | $-78.01 Million | $-135.83 Million | $205.10 Million | ▼ -231.2% |
| 2019 | -0.11x | $-22.44 Million | $-44.66 Million | $195.47 Million | — |